A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Glyburide in Healthy Volunteers
Condition: HealthyInterventions: Drug: Glyburide; Drug: Canagliflozin (JNJ-28431754)Sponsors: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed - verified December 2012
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials